Xiongyu Wu

Principal Research Engineer

Förste forskningsingenjör

Presentation

Publications

2024

Karin Lindbom, Caitlyn Norman, Steven Baginski, Lucas Krebs, Darta Stalberga, Tobias Rautio, Xiongyu Wu, Robert Kronstrand, Henrik Green (2024) Human metabolism of the semi-synthetic cannabinoids hexahydrocannabinol, hexahydrocannabiphorol and their acetates using hepatocytes and urine samples Drug Testing and Analysis Continue to DOI

2023

Afshan Begum, Jun Zhang, Dean Derbyshire, Xiongyu Wu, Peter Konradsson, Per Hammarström, Eleonore von Castelmur (2023) Transthyretin Binding Mode Dichotomy of Fluorescent trans-Stilbene Ligands ACS Chemical Neuroscience, Vol. 14, p. 820-828 Continue to DOI
Steven R. Baginski, Tobias Rautio, Lorna A. Nisbet, Karin Lindbom, Xiongyu Wu, Johan Dahlén, Craig Mckenzie, Henrik Green (2023) The metabolic profile of the synthetic cannabinoid receptor agonist ADB-HEXINACA using human hepatocytes, LC-QTOF-MS and synthesized reference standards Journal of Analytical Toxicology, Vol. 47, p. 826-834 Continue to DOI
Robert Kronstrand, Markus Roman, Anna Johansson, Xiongyu Wu, Henrik Gréen, Michael T. Truver (2023) Rilmazafone: A Designer Benzodiazepine Pro-Drug Involved in Fatal Intoxications Journal of Analytical Toxicology, Vol. 47, p. 640-643 Continue to DOI
Tobias Rautio, Daan Vangerven, Johan Dahlén, Shimpei Watanabe, Robert Kronstrand, Svante Vikingsson, Peter Konradsson, Xiongyu Wu, Henrik Gréen (2023) In vitro metabolite identification of acetylbenzylfentanyl, benzoylbenzylfentanyl, 3-fluoro-methoxyacetylfentanyl, and 3-phenylpropanoylfentanyl using LC-QTOF-HRMS together with synthesized references Drug Testing and Analysis, Vol. 15, p. 711-729 Continue to DOI

News